Immunogenicity testing (clinical)
Used to assess the capacity of a biotherapeutic to evoke an immune response. Three-tiered approach to immunoanalysis with screening and confirmation followed by antibody titer assessments used to determine a drug's immunogenic potential. Diverse array of innovative technology in both single- and multi-site clinical programs.